Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.37% |
| 2 | Financials | 4.87% |
| 3 | Healthcare | 3.8% |
| 4 | Consumer Discretionary | 3.79% |
| 5 | Industrials | 3.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Johnson & Johnson
JNJ
$632B
| $58.8M | 0.03% |
421,867
-1,824,137
| -81% | -$252M |
|
|
627
PUT
RTX Corp
RTX
$297B
| $58.7M | 0.03% |
716,321
+72,140
| +11% | +$6.03M |
|
628
PUT
Align Technology
ALGN
$12.5B
| $58.7M | 0.03% |
214,400
-79,800
| -27% | -$24.1M |
|
629
Hanover Insurance
THG
$7.77B
| $58.5M | 0.03% |
456,146
-129,447
| -22% | -$15.7M |
|
630
Deere & Co
DE
$165B
| $58.4M | 0.03% |
352,591
+261,784
| +288% | +$40.7M |
|
631
Canadian Pacific Kansas City
CP
$82.6B
| $58.4M | 0.03% |
1,238,905
+745,795
| +151% | +$33.3M |
|
632
Keurig Dr Pepper
KDP
$42.3B
| $58.3M | 0.03% |
2,018,905
-586,864
| -23% | -$16.7M |
|
633
KB Home
KBH
$3.45B
| $58.3M | 0.03% |
2,264,140
+290,737
| +15% | +$7.48M |
|
634
PUT
Medtronic
MDT
$116B
| $58.2M | 0.03% |
597,400
+24,500
| +4% | +$2.24M |
|
635
Merck
MRK
$334B
| $58.1M | 0.03% |
726,607
-604,870
| -45% | -$46.3M |
|
636
iShares Core MSCI EAFE ETF
IEFA
$196B
| $58M | 0.03% |
+945,052
| New | +$57.9M |
|
637
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.5B
| $58M | 0.03% |
972,400
+348,400
| +56% | +$20.4M |
|
638
CALL
eBay
EBAY
$46.5B
| $57.9M | 0.03% |
1,466,200
-1,805,300
| -55% | -$67.9M |
|
639
Liberty Broadband Class C
LBRDK
$5.29B
| $57.4M | 0.03% |
550,440
+231,429
| +73% | +$22.8M |
|
640
Clorox
CLX
$12.9B
| $57.2M | 0.03% |
373,695
+300,089
| +408% | +$45.8M |
|
641
Marathon Petroleum
MPC
$100B
| $57.1M | 0.03% |
1,022,287
-96,706
| -9% | -$5.29M |
|
642
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$44B
| $57M | 0.03% |
615,200
-603,100
| -50% | -$54.2M |
|
643
CALL
Sarepta Therapeutics
SRPT
$1.95B
| $56.9M | 0.03% |
374,300
+55,300
| +17% | +$6.72M |
|
|
BHVN
644
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $56.6M | 0.03% |
1,292,502
+593,727
| +85% | +$33.5M |
|
645
Saic
SAIC
$5.35B
| $56.4M | 0.03% |
651,936
+317,494
| +95% | +$24.9M |
|
646
Macerich
MAC
$6.99B
| $56.4M | 0.03% |
1,684,866
+396,110
| +31% | +$15.6M |
|
647
Tyler Technologies
TYL
$13.5B
| $56.4M | 0.03% |
260,970
+177,369
| +212% | +$38.5M |
|
648
Equity Residential
EQR
$24.7B
| $56.1M | 0.03% |
738,303
+286,932
| +64% | +$21.9M |
|
649
PUT
Zoom
ZM
$32.2B
| $55.9M | 0.03% |
+630,100
| New | +$51.8M |
|
|
650
Align Technology
ALGN
$12.5B
| $55.9M | 0.03% |
204,176
+105,993
| +108% | +$32M |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.4% of assets, down from 5.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.